IVVD

Invivyd, Inc. - Common Stock (IVVD)

About Invivyd, Inc. - Common Stock (IVVD)

Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers ADG20, a monoclonal antibody, targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in New Haven, CT.

Details

Daily high

$0.82

Daily low

$0.77

Price at open

$0.79

52 Week High

$3.07

52 Week Low

$0.53

Market cap

231.5M

Dividend yield

Volume

55,552

Avg. volume

4.3M

P/E ratio

-2.11

Invivyd, Inc. - Common Stock News